| Dr David Keydai Chang, MD | |
|
1616 Westgate Cir, Suite 210, Brentwood, TN 37027-8019 | |
| (615) 844-6234 | |
| (615) 844-6235 |
| Full Name | Dr David Keydai Chang |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1616 Westgate Cir, Brentwood, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619981875 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 26541 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Keydai Chang, MD 1616 Westgate Cir, Suite 210, Brentwood, TN 37027-8019 Ph: (615) 844-6234 | Dr David Keydai Chang, MD 1616 Westgate Cir, Suite 210, Brentwood, TN 37027-8019 Ph: (615) 844-6234 |
News Archive
NCKU President, Academician Michael Ming-Chiao Lai, signed Technology Transfer Agreement in this morning with Mr. Tou-Hsiung Yang, Chairman of Vedan International (Holding) Ltd, witnessed by Vedan Biotechnology President Shih-An (Raymond) Yang and the inventor, Prof. Huey-Lang Yang of the NCKU Institute of Biotechnology.
LaVision BioTec, developers of advanced microscopy solutions for the life sciences, will demonstrate their latest light sheet microscope, the UltraMicroscope II at the forthcoming analytica 2016 meeting in Munich.
Men who continued to smoke after a cancer diagnosis had an increased risk of death compared with those who quit smoking after diagnosis, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
Lundbeck Inc. today announced the presentation of results from an open-label extension study of Xenazine- (tetrabenazine) for the treatment of chorea associated with Huntington's disease (HD). Data from this study demonstrated that after an 80-week treatment period, subjects treated with Xenazine experienced a statistically significant reduction in chorea score (p< 0.0001) as measured using the Unified Huntington's Disease Rating Scale (UHDRS) compared with baseline.
Acromegaly is a chronic, life-threatening disease triggered by a benign tumour of the pituitary gland causing excessive growth hormone release. Oversupply of growth hormone stimulates liver, fat and kidney cells to produce excess levels of Insulin-Like Growth Factor I (IGFI), which causes abnormal growth of the bones of the hands, face and feet and bodily organs.
› Verified 6 days ago
Dr. Brian Joseph Morgan, D.O Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 5314 Maryland Way, Brentwood, TN 37027 Phone: 844-291-4535 | |
Michael L Edgeworth, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 912 Stuart Ln, Brentwood, TN 37027 Phone: 615-406-4994 | |
Ryan P Oakley, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 5300 Maryland Way, Brentwood, TN 37027 Phone: 615-224-9800 Fax: 615-224-9840 | |
Phyleen Stewart-ramage, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 5300 Maryland Way, Suite 101, Brentwood, TN 37027 Phone: 615-507-2082 | |
Mrs. Virginia Sinclair Gardner, APRN Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 7101 Peach Ct Ste 200, Brentwood, TN 37027 Phone: 615-212-9299 Fax: 615-747-1808 | |
Dr. Jonathan Becker, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 5300 Maryland Way, Suite #103, Brentwood, TN 37027 Phone: 615-224-9800 Fax: 615-224-9840 | |
Dr. Ronald E Wilson, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 343 Franklin Rd, Ste 200, Brentwood, TN 37027 Phone: 615-661-6365 Fax: 615-661-5981 |